2020
DOI: 10.18087/cardio.2020.6.n994
|View full text |Cite
|
Sign up to set email alerts
|

Dynamics of Parameters of Transmitral Blood Flow and Markers of Myocardial Fibrosis in Patients with Myocardial Infarction

Abstract: Aim      To study possible correlations between echocardiography (EchoCG) indexes and markers of myocardial fibrosis, procollagen I C-terminal propeptide (PICP) and procollagen III N-terminal propeptide (PIIINP) during one year following ST-segment elevation myocardial infarction (STEMI).Material and methods  120 patients with STEMI were evaluated. EchoCG was used to assess dimensions and volumes of heart chambers, left ventricular (LV) systolic function, mean pulmonary arterial pressure (mPAP), and indexes of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Additionally, low miR-26a plasma level is highly correlated with certain markers (e.g., CK-MB and troponin I) in STEMI patients ( Chiang et al, 2020 ), and immunoreactivity of Nε-(carboxymethyl)lysine is positively correlated with NT-proBNP and cardiac fibrosis ( Nogami et al, 2020 ). Furthermore, abnormal myocardial collagen I and III release certain peptides in the circulation as fibrotic markers ( Nikolov and Popovski, 2022 ), such as PICP and PIIINP, directly correlating with indexes of cardiac diastolic function ( Osokina et al, 2020 ). Furthermore, serum PIIINP of ≥381.4 ng/ml on the 12th day increases the risk of cardiac fibrosis 1 year after the disease onset in STEMI patients with preserved ejection fraction (EF) of I–III degree ( Osokina et al, 2021 ).…”
Section: Evaluations Of Cardiac Fibrosismentioning
confidence: 99%
“…Additionally, low miR-26a plasma level is highly correlated with certain markers (e.g., CK-MB and troponin I) in STEMI patients ( Chiang et al, 2020 ), and immunoreactivity of Nε-(carboxymethyl)lysine is positively correlated with NT-proBNP and cardiac fibrosis ( Nogami et al, 2020 ). Furthermore, abnormal myocardial collagen I and III release certain peptides in the circulation as fibrotic markers ( Nikolov and Popovski, 2022 ), such as PICP and PIIINP, directly correlating with indexes of cardiac diastolic function ( Osokina et al, 2020 ). Furthermore, serum PIIINP of ≥381.4 ng/ml on the 12th day increases the risk of cardiac fibrosis 1 year after the disease onset in STEMI patients with preserved ejection fraction (EF) of I–III degree ( Osokina et al, 2021 ).…”
Section: Evaluations Of Cardiac Fibrosismentioning
confidence: 99%